CD19/CD22 tandem CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/CD22 tandem CAR T cells, covering 2019-04-17 to 2019-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 [Phase 1, Phase 2]